Veldoreotide TFA 产品活性：Veldoreotide (DG3173) TFA 是一种生长抑素类似物，可结合并激活生长抑素受体 (SSTR) 2/4/5。与Octreotide (HY-P0036) 相比，Veldoreotide 在腺瘤中抑制生长激素分泌的比例更高。Veldoreotide 有被用作镇痛剂的潜力。 产品来源： https://www.medchemexpress.cn/veldoreotide-tfa.html 研究领域：GPCR/G Protein | Neuronal Signaling 作用靶点：Somatostatin Receptor In Vitro: Veldoreotide stimulates the SST2, SST4, and SST5 receptors with high potency and efficacy in the HEK293 cells, co-expressing these receptors with the GIRK2 channels; EC50s of 37.6 ± 4.5 nM, 31.3 ± 14.4 nM and 10.5 ± 3.4 nM for GIRK2-SST2, GIRK2-SST4 and GIRK2-SST5, respectively. Veldoreotide (10 μM; 24 h) inhibits SST4-expressing BON-1 cells. Veldoreotide (DG3173) (100 nM or 1 μM; 6 h) inhibits GH secreation in adenomas with an IC50 of 0.49 nM. 相关产品：Bioactive Compound Library Plus | Peptide Library | Octreotide | Cortistatin-14 | Pasireotide acetate | MK-4256 | CYN 154806 TFA | Cyclosomatostatin | AGI-41998 | Paltusotine | SSTR5 antagonist 1 | Pasireotide ditrifluoroacetate | BIM-23056 | J-2156 TFA | SSTR5 antagonist 2 hydrochloride | AGI-43192 | DOTA-LM3 TFA | CH 275 | PRL 2915 | TT-232 | Cortistatin 29 | BIM-23190 hydrochloride | L-803087 | Veldoreotide | Angiopeptin TFA | DOTA-JR11 | L-817818 品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；设有专业的实验中心和严格的质控、验证体系；提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；产品的生物活性多经各国客户实验验证；Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；与世界各大制药公司及知名科研机构建立了长期的合作。